%0 Journal Article
%T Diabetes and Hypertension among Patients Receiving Antiretroviral Treatment Since 1998 in Senegal: Prevalence and Associated Factors
%A Assane Diouf
%A Amandine Cournil
%A Khadidiatou Ba-Fall
%A Nd豕ye Fatou Ngom-Gu豕ye
%A Sabrina Eymard-Duvernay
%A Ibrahima Ndiaye
%A Gilbert Batista
%A Papa Mandoumb谷 Gu豕ye
%A Pape Samba Ba
%A Bernard Taverne
%A Eric Delaporte
%A Papa Salif Sow
%J ISRN AIDS
%D 2012
%R 10.5402/2012/621565
%X Cardiovascular risk factors in people on antiretroviral treatment (ART) are poorly documented in resource-constrained settings. A cross-sectional study was conducted in 2009 to assess prevalence of diabetes and hypertension in a sample of 242 HIV-infected patients who had initiated ART between 1998 and 2002 in Dakar, Senegal (ANRS 1215 observational cohort). World Health Organization (WHO) criteria were applied to diagnose diabetes and hypertension. Multiple logistic regressions were used to identify factors associated with diabetes and hypertension. Patients had a median age of 46 years and had received ART for a median duration of about 9 years. 14.5% had diabetes and 28.1% had hypertension. Long duration of ART (≡119 months), older age, higher body mass index (BMI), and higher levels of total cholesterol were associated with higher risks of diabetes. Older age, higher BMI at ART initiation, and higher levels of triglycerides were associated with higher risk of hypertension. This study shows that diabetes and hypertension were frequent in these Senegalese HIV patients on ART. It confirms the association between duration of ART and diabetes and highlights the need to implement programs for prevention of cardiovascular risk factors in HIV patients from resource-constrained settings. 1. Introduction In December 2010, over five million people were on antiretroviral treatment (ART) in Sub-Saharan Africa [1]. In Senegal, this number reached 18,000 at the end of 2011, corresponding to a coverage rate of 78% [2]. The efficacy of ART has led to a significant reduction in mortality among people living with HIV [3每6], causing an increase in their life expectancy, which nevertheless remains below that of the general population [7每10]. This excess mortality is partially related to immunodepression but also organic and metabolic disorders that are not classified as AIDS [4, 11每16]. These disorders have multifactor causes. The underlying physiopathological mechanisms have not been clearly established. Nevertheless, it is recognized that they involve phenomena related to the virus [17每21], to antiretrovirals (ARVs) [22每26], and to the host [27每31]. These mechanisms contribute to noninfectious diseases including diabetes and hypertension, which are two major risk factors of cardiovascular disease and are associated with increased mortality and morbidity. Available data on prevalence and the factors associated with diabetes and hypertension have dealt with populations of varying ages and whose duration of ARV exposure varied greatly. These studies have rarely addressed
%U http://www.hindawi.com/journals/isrn.aids/2012/621565/